The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
We investigated the in vivo function of the B7 family member B7-H3 (also known as B7RP-2) by gene targeting. B7-H3 inhibited T cell proliferation mediated by antibody to T cell receptor or allogeneic antigen-presenting cells. B7-H3-deficient mice developed more severe airway inflammation than did wild-type mice in conditions in which T helper cells differentiated toward type 1 (T(H)1) rather than type 2 (T(H)2). B7-H3 expression was consistently enhanced by interferon-gamma but suppressed by interleukin 4 in dendritic cells. B7-H3-deficient mice developed experimental autoimmune encephalomyelitis several days earlier than their wild-type littermates, and accumulated higher concentrations of autoantibodies to DNA. Thus, B7-H3 is a negative regulator that preferentially affects T(H)1 responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, CD276 (B7-H3), known to augment Tregs and inhibit T cell responses (Costa et al., 2018, Prasad et al., 2004, Suh et al., 2003), was expressed most prominently on CAFs and TSKs.”
From Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma (2020) · cites this paper as Suh et al., 2003
In the citing paper
“B7H3 has been shown to promote tumor metastasis and invasion via suppression of both CD8+ and CD4 + T cell proliferation and activity86,87.”
From The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancer (2025) · cites this paper as [87]
Citations
Cites
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
Self-citationNishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749 · cited 1×
“The idea that PD-1 has an immune inhibitory function is supported by the phenotype of PD-1-deficient mice, which develop lupus-like diseases or autoimmune dilated cardiomyopath”
BackgroundCD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 1×
“gif" NDATA ITEM> ]> An optimal T cell response is achieved by a combination of signals delivered through the antigen-specific T cell receptor (TCR) and accessory signals that are either stimulatory or inhibitor”
BackgroundDong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Cited by
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
“These studies include the finding that B7-H3-blocking antibodies exacerbate disease in the experimental autoimmune encephalomyelitis (EAE) murine model as well as in several other models (Suh et al., 2003).”
BackgroundGreenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
“The repertoire of negative regulators expressed on T lymphocytes has increased in scope and complexity with the recent delineation of B- and T-lymphocyte attenuator (68) and a further as-yet-unidentified molecule bound by B7-H3 (62).”
BackgroundCo-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
Chen, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1349 · Cited by 1,257
“By adenovirus-mediated expression of GM-CSF and IL-12 in airways to pre-sensitize T H 1 cells, lung infiltration of lymphocytes and macrophages is increased to a greater degree in B7-H3 -knockout mice than in control mice after exposure to a model antige”
BackgroundNovel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1091-2 · Cited by 1,145
“But recently studies reported that B7-H3 was involved in the inhibition of T cells [121, 122].”
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Ji, A. L., Rubin, A. J., Thrane, K., Jiang, S., Reynolds, D. L., Meyers, R. M., Guo, M. G., George, B. M., Mollbrink, A., Bergenstråhle, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.039 · Cited by 1,117
“Interestingly, CD276 (B7-H3), known to augment Tregs and inhibit T cell responses (Costa et al., 2018; Prasad et al., 2004; Suh et al., 2003), was expressed most prominently on CAFs and TSKs.”
BackgroundMolecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2428 · Cited by 582
“In particular, coculture with regulatory T cells (7), IFNg , lipopolysaccharide (LPS), or anti-CD40 in vitro stimulation (8) all induce the expression of B7-H3 on dendritic cells (DC).”
BackgroundCheckpoint Blockade in Cancer Immunotherapy
Korman, A. J., Peggs, K. S., & Allison, J. P. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90008-x · Cited by 570
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.002 · Cited by 542
“, 2005) and coinhibitory (Leitner et al., 2009; Prasad et al., 2004; Suh et al., 2003) functions for B7-H3.”
InfluentialDu, H., Hirabayashi, K., Ahn, S., Kren, N. P., Montgomery, S. A., Wang, X., Tiruthani, K., Mirlekar, B., Michaud, D., Greene, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.002 · Cited by 479
“Other studies support a negative immune regulatory role of B7-H3 in models of graft-versus-host disease, cardiac allograft rejection, airway inflammation, and autoimmune encephalomyelitis (Leitner et al., 2009; Prasad et al., 2004; Suh et al., 2003; Ueno et al., 2012; Veenstraet al., 2015; Vigdorovich etal., 2013).”
ResultSenescence-Associated Exosome Release from Human Prostate Cancer Cells
Lehmann, B. D., Paine, M. S., Brooks, A. M., McCubrey, J. A., Renegar, R. H., Wang, R., & Terrian, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6538 · Cited by 464
Seaman, S., Zhu, Z., Saha, S., Zhang, X. M., Yang, M. Y., Hilton, M. B., Morris, K., Szot, C., Morris, H., Swing, D. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.03.005 · Cited by 423
“Cd276 KO mice were born at expected Mendelian frequencies, showed no obvious phenotype and were fertile, consistent with previous studies and supporting the idea that CD276 function may be largely redundant or dispensable under normal unchallenged conditions (Suh et al., 2003).”
ResultZang, X., Thompson, R. H., Al-Ahmadie, H. A., Serio, A. M., Reuter, V. E., Eastham, J. A., Scardino, P. T., Sharma, P., & Allison, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709802104 · Cited by 401
B7-H3: An Attractive Target for Antibody-based Immunotherapy
Kontos, F., Michelakos, T., Kurokawa, T., Sadagopan, A., Schwab, J. H., Ferrone, C. R., & Ferrone, S. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2584 · Cited by 389
“B7-H3 shares 20%–27% amino acid identity with other B7 family ligands (7).”
BackgroundInfluentialUnger, W. W. J., Laban, S., Kleijwegt, F. S., van der Slik, A. R., & Roep, B. O. (2009) · European Journal of Immunology · doi:10.1002/eji.200839103 · Cited by 395
Cancer prevention and therapy through the modulation of the tumor microenvironment
Casey, S. C., Amedei, A., Aquilano, K., Azmi, A. S., Benencia, F., Bhakta, D., Bilsland, A. E., Boosani, C. S., Chen, S., Ciriolo, M. R., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.007 · Cited by 372
Murine B7-H3 is a negative regulator of T cells
Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2500 · Cited by 368
“(35), although the physiological significance of this regulation is unclear at this stage.”
BackgroundDendritic cell-mediated T cell polarization
de Jong, E. C., Smits, H. H., & Kapsenberg, M. L. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0167-1 · Cited by 367
“However, several other factors such as TGF-b, novel inhibitory molecules of the B7 family [PD-L1 (B7-H1), PD-L2 (B7-DC), B7-H3, B7-H4] [69, 96, 105, 107, 113], members of the Notch signaling pathway (Serrate1) [47, 132] or ILT3 and ILT4 are or may also be involved as candidate molecules expressed by DC that induce key…”
BackgroundNK Cell-Based Immune Checkpoint Inhibition
Khan, M., Arooj, S., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00167 · Cited by 356
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Shin, D. S., & Ribas, A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.006 · Cited by 346
Manipulating dendritic cell biology for the active immunotherapy of cancer
O'Neill, D. W., Adams, S., & Bhardwaj, N. (2004) · Blood · doi:10.1182/blood-2003-12-4392 · Cited by 339
“B7x transmits an inhibitory signal via BTLA,(150) and B7-H3 can also transmit an inhibitory signal, but through an unknown receptor.(151) Thromboxane A2 (TXA2) secreted by the DCs also attenuates the DC-T cell interaction via the thromboxane receptor (TP) on the T cell.”
BackgroundThe B7 Family and Cancer Therapy: Costimulation and Coinhibition
Zang, X., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1030 · Cited by 336
Lee, Y.-H., Martin-Orozco, N., Zheng, P., Li, J., Zhang, P., Tan, H., Park, H. J., Jeong, M., Chang, S. H., Kim, B.-S., et al. (2017) · Cell Research · doi:10.1038/cr.2017.90 · Cited by 328
Self-citationPD‐L1 expression on tolerogenic APCs is controlled by STAT‐3
Wölfle, S. J., Strebovsky, J., Bartz, H., Sähr, A., Arnold, C., Kaiser, C., Dalpke, A. H., & Heeg, K. (2011) · European Journal of Immunology · doi:10.1002/eji.201040979 · Cited by 323
The B7 family of immune-regulatory ligands.
Collins, M. A., Ling, V., & Carreno, B. M. (2005) · Genome biology · doi:10.1186/gb-2005-6-6-223 · Cited by 388
“Expression of PD-L1 and PD-L2, the independent ligands for the PD-1 receptor, is differentially regulated by cytokines: interleukins IL-4 and IL-13 upregulate PD-L2 [29,30], whereas inflammatory cytokines, primarily interferon- , modulate PD-L1 expression [3,31].”
Emerging targets in cancer immunotherapy
Burugu, S., Dancsok, A. R., & Nielsen, T. O. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.001 · Cited by 314
CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
Wang, C., Li, Y., Jia, L., Kim, J. K., Li, J., Deng, P., Zhang, W., Krebsbach, P. H., & Wang, C.-Y. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.011 · Cited by 304
B7-H3 and B7-H4 expression in non-small-cell lung cancer
Sun, Y., Wang, Y., Zhao, J., Gu, M., Giscombe, R., Lefvert, A. K., & Wang, X. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.05.012 · Cited by 316
B7-H3/CD276: An Emerging Cancer Immunotherapy
Zhou, W.-T., & Jin, W.-L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701006 · Cited by 295
Castriconi, R., Dondero, A., Augugliaro, R., Cantoni, C., Carnemolla, B., Sementa, A. R., Negri, F., Conte, R., Corrias, M. V., Moretta, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405025101 · Cited by 294
B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction
Leitner, J., Klauser, C., Pickl, W. F., Stöckl, J., Majdic, O., Bardet, A. F., Kreil, D. P., Dong, C., Yamazaki, T., Zlabinger, G., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200839028 · Cited by 290
“In contrast to its first description as a costimulatory molecule and potent inducer of IFN-γ [2], several studies have found B7-H3 to inhibit T cell responses [3, 5, 7].”
Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Loo, D., Alderson, R. F., Chen, F. Z., Huang, L., Zhang, W., Gorlatov, S., Burke, S., Ciccarone, V., Li, H., Yang, Y., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0715 · Cited by 284
“Silencing of B7-H3 expression has also been reported to regulate intracellular signaling of breast cancer cells and modulate chemotherapy resistance (34).”
BackgroundMolecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains
Steinberger, P., Majdic, O., Derdak, S. V., Pfistershammer, K., Kirchberger, S., Klauser, C., Zlabinger, G., Pickl, W. F., Stöckl, J., & Knapp, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2352 · Cited by 276
“lenged with EL-4 cells transfected to express B7-H3 (8, 9).”
BackgroundVSIG4, a B7 family-related protein, is a negative regulator of T cell activation
Vogt, L., Schmitz, N., Kurrer, M. O., Bauer, M., Hinton, H. I., Behnke, S., Gatto, D., Sebbel, P., Beerli, R. R., Sonderegger, I., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25673 · Cited by 272
Crispen, P. L., Sheinin, Y., Roth, T. J., Lohse, C. M., Kuntz, S. M., Frigola, X., Thompson, R. H., Boorjian, S. A., Dong, H., Leibovich, B. C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0536 · Cited by 272
“experimental autoimmune encephalitis, thus implicating B7-H3 as an inhibitor of TH1-mediated immunity (22).”
BackgroundBoorjian, S. A., Sheinin, Y., Crispen, P. L., Farmer, S. A., Lohse, C. M., Kuntz, S. M., Leibovich, B. C., Kwon, E. D., & Frank, I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0731 · Cited by 270
Mazini, L., Ezzoubi, M., & Malka, G. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02006-w · Cited by 267
“This selection should be optimized with other markers such as CD13, CD73, CD63, CD271, CD274, and CD276 for more reproducible identification or selection purposes [126, 128, 134].”
BackgroundRoth, T. J., Sheinin, Y., Lohse, C. M., Kuntz, S. M., Frigola, X., Inman, B. A., Krambeck, A. E., Mckenney, M. E., Karnes, R. J., Blute, M. L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1068 · Cited by 267
“In contrasting studies, B7-H3 has been shown to impair type 1 T-helper cell responses and inhibit cytokine production (10).”
BackgroundResultXu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4517 · Cited by 264
“B7-H3 preferentially down-regulated TH1-mediated immune response in B7-H3–deficient mice (5), and 4Ig-B7-H3 inhibited natural killer (NK) cell–mediated lysis of neuroblastoma cells by interacting with a putative inhibitory receptor on the surface of NK cells (6).”
Novel diagnostic biomarkers for prostate cancer
Madu, C. O., & Lu, Y. (2010) · Journal of Cancer · doi:10.7150/jca.1.150 · Cited by 261
“B7 (or B7-H3) protein is believed to function as an accessory co-regulator of T cell responses subsequent to initial antigen priming (196, 197).”
BackgroundTumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
Zang, X., Sullivan, P. S., Soslow, R. A., Waitz, R., Reuter, V. E., Wilton, A., Thaler, H. T., Arul, M., Slovin, S. F., Wei, J., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.95 · Cited by 249
T‐cell tolerance or function is determined by combinatorial costimulatory signals
Nurieva, R., Thomas, S., Nguyen, T., Martin‐Orozco, N., Wang, Y., Kaja, M., Yu, X., & Dong, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601146 · Cited by 245
“Negative costimulatory molecules PD-1, B7-H3 and B7S1 have been shown to regulate T-cell activation thresholds, and loss of their action often resulted in greater susceptibility to autoimmune diseases (Sharpe and Freeman, 2002; Prasad et al, 2003, 2004; Suh et al, 2003).”
BackgroundNew B7 Family Checkpoints in Human Cancers
Ni, L., & Dong, C. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0761 · Cited by 244
“Suh and colleagues (22) found that murine B7-H3 inhibited T-cell proliferation mediated by antibody to T-cell receptor or allogeneic antigen-presenting cells.”
BackgroundCamilleri, E. T., Gustafson, M. P., Dudakovic, A., Riester, S. M., Garces, C. G., Paradise, C. R., Takai, H., Karperien, M., Cool, S., Sampen, H.-J. I., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0370-8 · Cited by 240
“However, the function of CD276 remains controversial as this molecule may act as a co-stimulatory molecule for T-cell activation and selectively stimulates the production of IFNγ [49], or may inhibit T-cell proliferation [50].”
BackgroundB7-H3, a checkpoint molecule, as a target for cancer immunotherapy
Yang, S., Wei, W., & Zhao, Q. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41105 · Cited by 233
“The proliferation of both CD4+ and CD8+ T cells could be inhibited by B7-H3 [24].”
BackgroundCell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 229
“These mice develop a more severe Th1-dependent airway inflammation compared with wild-type mice and higher antibody titers and earlier disease onset during experimental autoimmune encephalomyelitis (190).”
BackgroundHashiguchi, M., Kobori, H., Ritprajak, P., Kamimura, Y., Kozono, H., & Azuma, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802423105 · Cited by 227
“However, as described in the introduction, the coinhibitory function of B7-H3 has also been reported (6, 7, 23, 24).”
BackgroundInfluentialThe third group of the B7‐CD 28 immune checkpoint family: HHLA 2, TMIGD 2, B7x, and B7‐H3
Janakiram, M., Shah, U. A., Liu, W., Zhao, A., Schoenberg, M. P., & Zang, X. (2017) · Immunological Reviews · doi:10.1111/imr.12521 · Cited by 225
Dagar, G., Gupta, A., Masoodi, T., Nisar, S., Merhi, M., Hashem, S., Chauhan, R., Dagar, M., Mirza, S., Bagga, P., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04292-3 · Cited by 205
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Zhao, B., Li, H., Xia, Y., Wang, Y., Wang, Y., Shi, Y., Xing, H., Qu, T., Wang, Y., & Ma, W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01364-7 · Cited by 205
“found that B7-H3-deficient mice exhibited accelerated progression of experimental autoimmune encephalomyelitis [96] and produced higher concentrations of DNA autoantibodies [91].”
BackgroundCAR T cells for brain tumors: Lessons learned and road ahead
Akhavan, D., Alizadeh, D., Wang, D., Weist, M. R., Shepphird, J. K., & Brown, C. E. (2019) · Immunological Reviews · doi:10.1111/imr.12773 · Cited by 214
Current Perspectives in Cancer Immunotherapy
Christofi, T., Baritaki, S., Falzone, L., Libra, M., & Zaravinos, A. (2019) · Cancers · doi:10.3390/cancers11101472 · Cited by 210
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
Xiong, D., Wang, Y., & You, M. (2020) · Nature Communications · doi:10.1038/s41467-020-18546-x · Cited by 208
The Roles of the New Negative T Cell Costimulatory Pathways in Regulating Autoimmunity
Khoury, S. J., & Sayegh, M. H. (2004) · Immunity · doi:10.1016/s1074-7613(04)00116-5 · Cited by 209
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
Zhao, R., Chinai, J. M., Buhl, S., Scandiuzzi, L., Ray, A., Jeon, H., Ohaegbulam, K. C., Ghosh, K., Zhao, A., Scharff, M. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303524110 · Cited by 208
“B7-H3 binds activated T cells, but the physiological role of this pathway is unclear, as both costimulatory and coinhibitory effects have been observed (24, 28, 29).”
BackgroundHofmeyer, K. A., Ray, A., & Zang, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805458105 · Cited by 201
“Both mouse and human B7-H3 inhibit CD4 T cell activation and the production of effector cytokines such as IFN- and IL-4 (7, 11, 18).”
BackgroundInfluentialPentcheva‐Hoang, T., Corse, E., & Allison, J. P. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00763.x · Cited by 203
“Furthermore, the identification of B7-H3 ⁄CD276 (24, 25) and B7x ⁄B7-H4 (26–28) as novel homologues of B7-1 and B7-2 that can inhibit T cells by binding to currently unknown receptors extends this family even further.”
BackgroundInfluentialThe role of herpesvirus entry mediator as a negative regulator of T cell–mediated responses
Wang, Y., Subudhi, S. K., Anders, R. A., Lo, J., Sun, Y., Blink, S., Wang, Y., Wang, J., Liu, X., Mink, K., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522982 · Cited by 197
“B7-H3 has also been shown to have both T costimulatory and coinhibitory functions, although its receptors have not yet been defined (29, 30).”
BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation
Nguyen, T., Liu, X. K., Zhang, Y., & Dong, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7354 · Cited by 195
“Human B7-H3 was first found to be a positive costimulator (15); recent studies by others suggested that mouse B7-H3 may serve as a negative regulator in T cell activation (16, 17).”
BackgroundZhang, G., Hou, J., Shi, J., Yu, G., Lu, B., & Zhang, X. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02723.x · Cited by 192
Kuipers, H., Muskens, F., Willart, M., Hijdra, D., van Assema, F. B. J., Coyle, A. J., Hoogsteden, H. C., & Lambrecht, B. N. (2006) · European Journal of Immunology · doi:10.1002/eji.200635978 · Cited by 191
Hendry, S. A., Farnsworth, R. H., Solomon, B., Achen, M. G., Stacker, S. A., & Fox, S. B. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00621 · Cited by 188
“Both molecules are thought to function as co-inhibitory signals limiting T cell activation (215, 216).”
BackgroundThe role of B7 family molecules in hematologic malignancy
Greaves, P., & Gribben, J. G. (2013) · Blood · doi:10.1182/blood-2012-10-385591 · Cited by 187
The New B7s: Playing a Pivotal Role in Tumor Immunity
Flies, D. B., & Chen, L. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802e085a · Cited by 189
Huang, Y., Zhang, H.-L., Li, Z.-L., Du, T., Chen, Y.-H., Wang, Y., Ni, H.-H., Zhang, K.-M., Mai, J., Hu, B.-X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22618-x · Cited by 183
Das, S., Suarez, G., Beswick, E. J., Sierra, J. C., Graham, D. Y., & Reyes, V. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3000 · Cited by 184
“Expression of B7-H1 and its effect on H. pylori infection To determine whether GEC express coinhibitory members of the B7 family, we performed RT-PCR of a panel of GEC (KATO III, N87, AGS, and HS738) to detect mRNA corresponding to B7-H1 and B7-DC are ligands for the inhibitory TCR PD-1, and B7-H3 is a related member…”
BackgroundInfluentialLuo, L., Chapoval, A. I., Flies, D. B., Zhu, G., Hirano, F., Wang, S., Lau, J. S., Dong, H., Tamada, K., Flies, A. S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5445 · Cited by 181
“However, there was only a small difference in Th1-mediated responses including experimental autoimmune encephalitis and CTL responses to LCMV viral infection (8), which are believed to be mediated or dependent on Th1 T cell responses.”
BackgroundMethodInfluentialWang, L., Zhang, Q., Chen, W., Shan, B., Ding, Y., Zhang, G., Cao, N., Liu, L., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070689 · Cited by 177
“Further data in support of a coinhibitory role of B7-H3 in the regulation of immune response came from in vivo experiments showing that Th1-mediated hypersensitivity, and that the onset of experimental autoimmune encephalomyelitis and allergic conjunctivitis were augmented in B7-H3 knock-out mice [28,29].”
BackgroundFine tuning the immune response through B7‐H3 and B7‐H4
Yi, K. H., & Chen, L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00768.x · Cited by 175
“Recombinant mouse and human B7-H3 proteins were shown to inhibit anti-CD3 mAb-induced T-cell proliferation, cytokine production, and activation of transcription factors, such as nuclear factor for activated T cells (NFAT), nuclear factor jB (NF-jB), and activator protein-1 (AP-1) (3, 19, 20).”
BackgroundB7-H3 role in the immune landscape of cancer.
Castellanos, J. R., Purvis, I. J., Labak, C. M., Guda, M. R., Tsung, A. J., Velpula, K. K., & Asuthkar, S. (2017) · Europe PMC (PubMed Central) · Cited by 205
Clinical importance of B7-H3 expression in human pancreatic cancer
Yamato, I., Sho, M., Nomi, T., Akahori, T., Shimada, K., Hotta, K., Kanehiro, H., Konishi, N., Yagita, H., & Nakajima, Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605375 · Cited by 169
“In vivo antibodymediated blockade of B7-H3 in mice has been reported to enhance T-cell activation and to lead to more severe forms of experimental autoimmune encephalitis (Suh et al, 2003; Prasad et al, 2004).”
BackgroundB7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
Yonesaka, K., Haratani, K., Takamura, S., Sakai, H., Kato, R., Takegawa, N., Takahama, T., Tanaka, K., Hayashi, H., Takeda, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2852 · Cited by 167
“Although B7-H3 was initially identified as an activator of T-cell function (32, 33), subsequent reports have shown that B7-H3 can cause T-cell dysfunction (37, 38).”
ResultLim, S., Liu, H., da Silva, L. M., Arora, R., Liu, Z., Phillips, J. B., Schmitt, D. C., Vu, T., McClellan, S., Lin, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1538 · Cited by 162
“Murine B7-H3 has been reported suppressing Th1 effector responses (38, 39).”
Regulation of T cell activation and tolerance by PDL2
Zhang, Y., Chung, Y., Bishop, C., Daugherty, B., Chute, H., Holst, P., Kurahara, C., Lott, F., Sun, N., Welcher, A. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601347103 · Cited by 159
Sun, J., Chen, L.-J., Zhang, G.-B., Jiang, J.-T., Zhu, M., Tan, Y., Wang, H.-T., Lu, B.-F., & Zhang, X.-G. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0841-1 · Cited by 159
“IFN-c was shown to induce the expression of B7-H3 in DCs [ 37 ] and was therefore included in our study.”
BackgroundMethodYin–Yang of costimulation: crucial controls of immune tolerance and function
Nurieva, R. I., Liu, X., & Dong, C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00769.x · Cited by 157
“B7-H3-deficient mice developed EAE earlier and accumulated higher concentrations of autoantibodies to DNA in aged mice (93).”
BackgroundKang, F., Ling, W., Jia, H.-C., Li, D., Li, H., Zhang, Y., & Sun, D. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0195-z · Cited by 161
“Others evidence showed that B7-H3 played an inhibitory role during autoimmune diseases [11,12].”
BackgroundScribner, J. A., Brown, J. G., Son, T., Chiechi, M., Li, P., Sharma, S., Li, H., De Costa, A., Li, Y., Chen, Y., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0116 · Cited by 158
The role of exosomes and microRNAs in senescence and aging
Xu, D., & Tahara, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.010 · Cited by 161
Aggarwal, C., Prawira, A., Antonia, S. J., Rahma, O. E., Tolcher, A. W., Cohen, R. B., Lou, Y., Hauke, R. J., Vogelzang, N. J., Zandberg, D. P., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004424 · Cited by 156
B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
Liu, H., Tekle, C., Chen, Y.-W., Kristian, A., Zhao, Y., Zhou, M., Liu, Z., Ding, Y., Wang, B., Mælandsmo, G. M., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0072 · Cited by 157
“B7-H3, a transmembrane protein with immunoglobulin-like structure (1), is known to have immunoregulatory properties with both inhibitory and stimulatory effects on the activation of T-cells (2-5).”
BackgroundLoos, M., Hedderich, D. M., Ottenhausen, M., Giese, N. A., Laschinger, M., Esposito, I., Kleeff, J. H., & Friess, H. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-463 · Cited by 152
“Indeed, IFN-γ has previously been shown to enhance surface expression of B7-H3 on bone marrow derived dendritic cells and on monocytes [18].”
BackgroundAbumaree, M., Jumah, M. A., Kalionis, B., Jawdat, D. M., Al-Khaldi, A., AlTalabani, A. A., & Knawy, B. A. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9385-4 · Cited by 149
“This is the first study which demonstrates that pMSCs isolated from chorionic villi by the explant method express a broad spectrum of cytokines, growth factor receptors (Tables 5 and 6) and costimulatory molecules (B7H3, CD273 and CD274) as well as the immune suppressive enzyme IDO, which can induce T cell death [40–4…”
BackgroundB7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
Arigami, T., Narita, N., Mizuno, R., Nguyen, L., Ye, X., Chung, A. P., Giuliano, A. E., & Hoon, D. S. �. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181f1939d · Cited by 148
New checkpoints in cancer immunotherapy
Ni, L., & Dong, C. (2017) · Immunological Reviews · doi:10.1111/imr.12524 · Cited by 149
Wu, C., Jiang, J., Tan, M., Zhu, Y., Ji, M., Xu, K., Zhao, J., Zhang, G., & Zhang, X. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.457 · Cited by 144
Estriol Generates Tolerogenic Dendritic Cells In Vivo That Protect against Autoimmunity
Papenfuss, T. L., Powell, N. D., McClain, M. A., Bedarf, A., Singh, A. J., Gienapp, I. E., Shawler, T. M., & Whitacre, C. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001322 · Cited by 152
B7‐H3‐mediated tumor immunology: Friend or foe?
Wang, L., Kang, F., & Shan, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28474 · Cited by 136
Adkisson, H. D., Milliman, C. L., Zhang, X., Mauch, K. A., Maziarz, R. T., & Streeter, P. R. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.09.004 · Cited by 143
Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
Vigdorovich, V. I., Ramagopal, U. A., Lázár‐Molnár, E., Sylvestre, E., Lee, J. S., Hofmeyer, K. A., Zang, X., Nathenson, S. G., & Almo, S. C. (2013) · Structure · doi:10.1016/j.str.2013.03.003 · Cited by 136
“…of B7-H3 remains unclear because it has been reported to stimulate (Chapoval et al., 2001; Hashiguchi et al., 2008; Kobori et al., 2010), inhibit (Suh et al., 2003; Prasad et al., 2004; Xu et al., 2006; Leitner et al., 2009; Chen et al., 2011), and have no effect (Steinberger et al., 2004) on T…”
InfluentialMahnke, K., Ring, S., Johnson, T., Schallenberg, S., Schönfeld, K., Storn, V., Bedke, T., & Enk, A. (2007) · European Journal of Immunology · doi:10.1002/eji.200636841 · Cited by 142
The B7/CD28 costimulatory family in autoimmunity
Keir, M. E., & Sharpe, A. H. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00242.x · Cited by 176
“Studies in B7-H3 mice also support an inhibitory function for B7-H3, particularly for Th1 responses (59).”
BackgroundQuandt, D., Fiedler, E., Boettcher, D., Marsch, W. C., & Seliger, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2268 · Cited by 139
“In contrast, an inhibitory role for B7-H3 on T cell effector functions has been documented, but the assays were not carried out with tumor cells, instead with APCs or with B7H3Ig (16, 64).”
BackgroundB7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
Zhang, Z., Jiang, C., Liu, Z., Yang, M., Tang, X., Wang, Y., Zheng, M., Huang, J., Zhong, K., Zhao, S., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.019 · Cited by 134
Dutta, S., Ganguly, A., Chatterjee, K., Spada, S., & Mukherjee, S. (2023) · Biology · doi:10.3390/biology12020218 · Cited by 151
Recent Advances in Dendritic Cell Biology
Adams, S., O’Neill, D. W., & Bhardwaj, N. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-2814-2 · Cited by 152
“B7-H3 and B7x are broadly expressed on many cell types and may be involved in attenuation of inflammatory responses in peripheral tissues (52, 53).”
BackgroundCai, D., Li, J., Liu, D., Hong, S., Qiao, Q., Sun, Q., Li, P., Lyu, N., Sun, T., Xie, S., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0305-2 · Cited by 136
Recent developments in immunotherapy for gastrointestinal tract cancers
Chong, X., Madeti, Y., Cai, J., Li, W., Cong, L., Lu, J., Mo, L., Liu, H., He, S., Yu, C., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01578-x · Cited by 146
T-Cell Costimulatory Pathways in Allograft Rejection and Tolerance
Clarkson, M. R., & Sayegh, M. H. (2005) · Transplantation · doi:10.1097/01.tp.0000168432.60022.99 · Cited by 139
Bluestone, J. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01019.x · Cited by 150
“B7-H3 is expressed on many cells of lymphoid and non-lymphoid tissues and its binding to an unidentified receptor on activated T cells might provide a negative feedback mechanism for Th1-mediated responses (38).”
Background
Metadata
- Authors
- Suh, W.-K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S., Bukczynski, J., Plyte, S., Elia, A., Wakeham, A., Itie, A., Chung, S., Da Costa, J., Arya, S., Horan, T., Campbell, P., Gaida, K., Ohashi, P. S., Watts, T. H., Yoshinaga, S. K., Bray, M. R., Jordana, M., & Mak, T. W.
- Affiliations
- University of Toronto (CA)
- McMaster University (CA)
- Amgen (United States) (US)
- Corresponding author
- Suh, Woong-Kyung
- Mak, Tak W
- ORCID
- Venue
- Nature Immunology
- Published
- 2003-08-17
- Volume
- 4
- Issue
- 9
- Pages
- 899-906
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2052644931
- Cited by
- 576
- References
- 47
- Citations by year
- 2026: 17 · 2025: 39 · 2024: 32 · 2023: 30 · 2022: 37 · 2021: 48 · 2020: 35 · 2019: 29 · 2018: 12 · 2017: 21 · 2016: 20 · 2015: 25 · 2014: 9 · 2013: 18 · 2012: 29
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- B7-H3, B7 family, T cell proliferation, airway inflammation, interferon-gamma, IL-4, dendritic cells, experimental autoimmune encephalomyelitis, negative regulation of immune response, gene targeting
- MeSH terms
- Animals, Autoantibodies, Dendritic Cells, Encephalomyelitis, Autoimmune, Experimental, Flow Cytometry, Interferon-gamma, Lymphocyte Activation, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Orthomyxoviridae, Receptors, Antigen, T-Cell, Vesicular stomatitis Indiana virus, Down-Regulation, Interleukin-4, B7-1 Antigen, Mice, Knockout, Th1 Cells, Mice, B7 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.